How to identify frailty in older patients with cancer? Available tools

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
Carine Bellera, Pierre Soubeyran

Abstract

Management of cancer in the elderly needs more attention than in younger patients mainly because of comorbidities and geriatric syndromes. Each frailty encountered will facilitate adverse events and complications which are more frequent and more severe in the elderly and have to be anticipated to control for the risk of organ failure and dependencies. Fortunately, tools which have been developed and validated by geriatricians, are available to the oncologists and their validity has been demonstrated in oncology. Yet, they are quite time-consuming and consequently available for a minority of patients. Furthermore, it appears that some of the older patients can be proposed standard therapy and do not need the intervention of geriatricians. This is the reason why screening tools have been developed and validated among which the G8 questionnaire appears to be one of the best. This approach is beginning to be implemented in the daily routine in France and abroad but their appropriate use according to cancer types and treatment intensity should be further improved for the benefit of our patients.

References

Feb 1, 1991·Journal of the American Geriatrics Society·D Podsiadlo, S Richardson
May 1, 1968·Journal of the American Geriatrics Society·B S LinnL Gurel
Dec 27, 1984·The New England Journal of Medicine·L Z RubensteinR L Kane
Dec 29, 2000·Journal of the American Geriatrics Society·R McCorkleM Torosian
Jun 30, 2001·JAMA : the Journal of the American Medical Association·L C WalterK E Covinsky
Feb 15, 2002·Journal of the American Geriatrics Society·D SalibaN S Wenger
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J AlexandreF Goldwasser
Jun 26, 2003·JAMA : the Journal of the American Medical Association·Saralyn H Allaire
Aug 16, 2003·Journal of the American Geriatrics Society·James S GoodwinJean L Freeman
Oct 16, 2004·Journal of General Internal Medicine·Elise C CareyKenneth E Covinsky
Dec 2, 2004·Journal of the American Geriatrics Society·Dan G Blazer, Celia F Hybels
Aug 12, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G FreyerE Pujade-Lauraine
Feb 16, 2006·JAMA : the Journal of the American Medical Association·Sei J LeeKenneth E Covinsky
May 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J SmithAntonio C Wolff
Aug 19, 2007·Journal of the American Geriatrics Society·Sei J LeeKenneth E Covinsky
Dec 11, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C ThieblemontB Coiffier
Dec 19, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Siran M KoroukianCynthia Owusu
Apr 13, 2011·The Lancet Oncology·Frédéric PeyradeUNKNOWN Groupe d'Etude des Lymphomes de l'Adulte (GELA) investigators
Jan 18, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C A BelleraP L Soubeyran
Apr 18, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre SoubeyranMuriel Rainfray
Sep 26, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stéphanie HoppePierre Soubeyran
Jun 18, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L DecosterM Extermann

❮ Previous
Next ❯

Citations

Sep 8, 2015·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·C Durdux, M Gisselbrecht

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.